WHO Approves Johnson & Johnson COVID-19 Vaccine For Emergency Use

Hamilton Nwosa
Writer
905m COVID-19 Shots Administered Worldwide – Report

Ad

$4.5bn: Court Admits More Evidence Against Emefiele

Justice Rahman Oshodi of the Special Offences Court sitting in Ikeja, Lagos, on October 9,2025, admitted more evidence against a former Governor of the Central Bank of Nigeria (CBN), Godwin Emefiele, in an alleged $4.5bn fraud. Emefiele is standing trial on a 19-count charge bordering on receiving gratification and corrupt demand preferred against him by…

NEITI Warns of Deepening Transparency Crisis, Says Nigeria Lost $3.3bn to Oil theft, Sabotage

By Obinna Uballa Nigeria lost an estimated 13.5 million barrels of crude oil valued at $3.3 billion to theft and pipeline sabotage between 2023 and 2024, the Nigeria Extractive Industries Transparency Initiative (NEITI) has revealed. Executive Secretary of NEITI, Dr. Ogbonnaya Orji, disclosed this on Thursday at the 2025 Association of Energy Correspondents of Nigeria…

Oil Eases over 1.5% after Gaza ceasefire

Summary Israel and Hamas agree to Gaza ceasefire, return of hostages US oil product supplied highest since December 2022, EIA says Stalled peace talks in Ukraine underpin prices Oil prices edged slightly lower on Thursday after Israel and the Palestinian militant group Hamas signed an agreement to cease fire in Gaza. Brent crude futures were…

Ad

The World Health Organization (WHO) on Friday approved Johnson & Johnson’s Covid-19 vaccine, after already authorising the jabs made by Pfizer-BioNTech and Oxford-AstraZeneca.

“Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic,” WHO chief Tedros Adhanom Ghebreyesus said in a statement.

The news comes after the single-dose jab won approval from the European Union on Thursday.

It has also received the green light from regulators in the United States, Canada and South Africa.

The World Health Organization said the Johnson & Johnson’s Covid-19 vaccine had been granted an “emergency use listing” which assesses the suitability of new health products during public health emergencies, and is quicker than the regular licensing system.

WHO authorisation paves the way for the jabs to be used as part of the Covax initiative aimed at ensuring equitable access to vaccines in poorer countries.

Some 500 million doses of the J&J jabs have been promised to the facility and the WHO hopes it can be rolled out through the scheme from July, if not earlier.

“We hope this new vaccine will help to narrow vaccine inequalities, and not deepen them,” Tedros told a briefing.

Clinical trials have found that the J&J shot was 67 percent effective at preventing people from getting Covid-19.

But that result considered all forms of Covid-19. The jab proved 85.4 percent effective at preventing severe disease.

And since this is a single-dose jab, WHO said it expected it to facilitate vaccination logistics in all countries.

“The sample data from large clinical trials shared by the company also shows that the vaccine is effective in older populations,” it said.

AFP

Ad

Unlocking Opportunities in the Gulf of Guinea during UNGA80
X whatsapp